{"id":"https://openalex.org/W2807916043","doi":"https://doi.org/10.1158/1535-7163.targ-17-b007","title":"Abstract B007: Potent antitumor activity of a novel and orally available small-molecule antagonist targeting the CD47/SIRP\u03b1 pathway","display_name":"Abstract B007: Potent antitumor activity of a novel and orally available small-molecule antagonist targeting the CD47/SIRP\u03b1 pathway","publication_year":2018,"publication_date":"2018-01-01","ids":{"openalex":"https://openalex.org/W2807916043","doi":"https://doi.org/10.1158/1535-7163.targ-17-b007","mag":"2807916043"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-17-b007","doi":"https://doi.org/10.1158/1535-7163.targ-17-b007","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-17-b007","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019251837","display_name":"Pottayil G. Sasikumar","orcid":"https://orcid.org/0000-0003-0681-9853","observed_orcids":["https://orcid.org/0000-0003-0681-9853"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pottayil G. Sasikumar","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055722819","display_name":"Gundala Chennakrishnareddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Chennakrishnareddy Gundala","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051605989","display_name":"Wesley Roy Balasubramanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Wesley R. Balasubramanian","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089283691","display_name":"Naremaddepalli S. Sudarshan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sudarshan S. Naremaddepalli","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040824450","display_name":"Archana Bhumireddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Archana Bhumireddy","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102271953","display_name":"Sandeep Patil","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sandeep S. Patil","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108664075","display_name":"Amit A. Dhudashiya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Amit A. Dhudashiya","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029535919","display_name":"Vijaysai Rayavarapu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vijaysai Rayavarapu","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076581588","display_name":"Anirudha Lakshminarasimhan","orcid":"https://orcid.org/0000-0002-3008-0350","observed_orcids":["https://orcid.org/0000-0002-3008-0350"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anirudha Lakshminarasimhan","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039267938","display_name":"Dodheri Syed Samiulla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dodheri S. Samiulla","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047387657","display_name":"Kiran B. Aithal","orcid":"https://orcid.org/0000-0001-7426-404X","observed_orcids":["https://orcid.org/0000-0001-7426-404X"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kiran Aithal","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074867808","display_name":"Girish Daginakatte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Girish Daginakatte","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065784113","display_name":"Murali Ramachandra","orcid":"https://orcid.org/0000-0003-4039-1491","observed_orcids":["https://orcid.org/0000-0003-4039-1491"]},"institutions":[{"id":"https://openalex.org/I4210152788","display_name":"Aurigene Discovery Technologies (India)","ror":"https://ror.org/05k1y3v43","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210152788"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Murali Ramachandra","raw_affiliation_strings":["Aurigene Discovery Technologies Limited, Bangalore, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aurigene Discovery Technologies Limited, Bangalore, India","institution_ids":["https://openalex.org/I4210152788"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210152788"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"1_Supplement","first_page":"B007","last_page":"B007"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12672","display_name":"Phagocytosis and Immune Regulation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd47","display_name":"CD47","score":0.8939999938011169},{"id":"https://openalex.org/keywords/sirpalpha","display_name":"SIRP\u03b1","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cd47-sirpalpha-interaction","display_name":"CD47-SIRP\u03b1 interaction","score":0.8949999809265137},{"id":"https://openalex.org/keywords/small-molecule-antagonists","display_name":"small molecule antagonists","score":0.8610000014305115},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.8500000238418579},{"id":"https://openalex.org/keywords/macrophage-phagocytosis","display_name":"macrophage phagocytosis","score":0.9200000166893005},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8140000104904175},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7260000109672546},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.6480000019073486},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.6959999799728394},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.4519999921321869},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5820000171661377},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2780104668","wikidata":"https://www.wikidata.org/wiki/Q21108354","display_name":"CD47","level":3,"score":0.8943108916282654},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.5334480404853821},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5277923941612244},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.48594820499420166},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4849384129047394},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4807698130607605},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4759088456630707},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44101250171661377},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.42422446608543396},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.42342591285705566},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.36915338039398193},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.34903812408447266},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33360180258750916},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32720792293548584},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.18358159065246582},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.09498399496078491}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-17-b007","doi":"https://doi.org/10.1158/1535-7163.targ-17-b007","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-17-b007","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2592953803","https://openalex.org/W4386939420","https://openalex.org/W3049368451","https://openalex.org/W3003989858","https://openalex.org/W2741854506","https://openalex.org/W4376506371","https://openalex.org/W4224028434","https://openalex.org/W2807568660","https://openalex.org/W3087190239","https://openalex.org/W2889258202"],"abstract_inverted_index":{"Abstract":[0],"Antibodies":[1],"targeting":[2,116,137,380],"PD-1":[3],"and":[4,27,71,93,120,143,164,172,283,311,375,394],"PD-L1":[5],"towards":[6],"stimulation":[7],"of":[8,16,37,67,81,97,113,126,174,185,193,196,203,236,259,273,302,325,372,387],"T":[9],"cells":[10,31],"have":[11,47],"revolutionized":[12],"cancer":[13,23,38,94,109],"therapy":[14],"because":[15],"the":[17,52,111,127,130,157,162,182,204,220,230,333,381,388],"highly":[18],"durable":[19],"response":[20],"in":[21,51,85,208,246,277,297,314,332],"multiple":[22],"indications.":[24],"Although":[25],"macrophages":[26,261],"other":[28],"myeloid":[29,68],"immune":[30,75,91],"offer":[32],"much":[33],"promise":[34],"as":[35,73,104,219,266],"effectors":[36],"immunotherapy,":[39],"efforts":[40],"to":[41,90,141,160,166,228,262],"modulate":[42],"them":[43],"for":[44,77,108,129,133,330],"therapeutic":[45,106],"benefit":[46],"gained":[48],"momentum":[49],"only":[50],"last":[53],"few":[54],"years.":[55],"The":[56,222,234,252],"CD47/signal":[57],"regulatory":[58],"protein":[59],"alpha":[60],"(SIRP\u03b1)":[61],"axis":[62],"is":[63,100],"a":[64,105,191,209,216,263,298,373],"critical":[65],"regulator":[66],"cell":[69],"activation":[70],"serves":[72],"an":[74,145],"checkpoint":[76],"macrophage-mediated":[78],"phagocytosis.":[79],"Because":[80],"its":[82],"frequent":[83],"upregulation":[84],"several":[86],"cancers,":[87],"CD47":[88,117,136,149,153,254,290],"contributes":[89],"evasion":[92],"progression.":[95],"Disruption":[96],"CD47-SIRP\u03b1":[98,198],"interaction":[99],"now":[101],"being":[102],"evaluated":[103],"strategy":[107],"with":[110,279],"use":[112,331],"monoclonal":[114],"antibodies":[115],"or":[118],"SIRP\u03b1,":[119],"engineered":[121],"receptor":[122],"decoys.":[123],"In":[124],"view":[125],"requirement":[128],"intravenous":[131],"dosing":[132],"all":[134],"reported":[135],"agents,":[138],"we":[139,189],"sought":[140],"discover":[142],"develop":[144],"orally":[146,327,376],"available":[147,268,377],"small-molecule":[148,243,378],"antagonist.":[150],"An":[151,287],"oral":[152,285,307],"agent":[154],"potentially":[155],"offers":[156],"convenience,":[158],"flexibility":[159],"adjust":[161],"dose":[163],"schedule":[165],"address":[167],"any":[168],"emergent":[169],"adverse":[170],"events,":[171],"ease":[173],"combination":[175],"therapy.":[176],"Through":[177],"rational":[178],"design":[179],"based":[180],"on":[181],"crystal":[183],"structure":[184],"CD47/SIRP\u03b1":[186,250,382],"interacting":[187],"interface,":[188],"generated":[190],"series":[192],"peptides":[194,205,224],"capable":[195],"disrupting":[197,249],"interactions.":[199],"Relative":[200],"binding":[201],"affinities":[202],"were":[206,225,239],"determined":[207],"newly":[210],"established":[211],"cellular":[212],"assay":[213],"that":[214],"utilizes":[215],"SIRP\u03b1-derived":[217],"peptide":[218,232],"probe.":[221],"high-affinity":[223],"further":[226,323],"truncated":[227],"identify":[229],"shortest":[231],"pharmacophore.":[233],"elements":[235],"this":[237],"pharmacophore":[238],"incorporated":[240],"into":[241],"nonpeptidic":[242],"scaffolds,":[244],"resulting":[245],"lead":[247,253,289],"compounds":[248,278],"interaction.":[251],"antagonists":[255],"induced":[256],"phagocytototic":[257],"activity":[258,371],"human":[260],"similar":[264],"extent":[265],"commercially":[267],"anti-CD47":[269],"antibodies.":[270],"Further":[271],"optimization":[272],"these":[274,326],"leads":[275],"resulted":[276],"desirable":[280],"physicochemical":[281],"properties":[282],"good":[284],"bioavailability.":[286],"advanced":[288],"antagonist":[291,379],"inhibited":[292],"primary":[293],"tumor":[294,316],"growth":[295],"(~90%TGI)":[296],"mouse":[299],"syngeneic":[300],"model":[301],"B-cell":[303],"lymphoma":[304],"upon":[305],"twice-a-day":[306],"dosing.":[308],"Biomarker":[309],"characterization":[310],"efficacy":[312],"studies":[313],"additional":[315],"models":[317],"are":[318],"ongoing.":[319],"These":[320],"findings":[321],"support":[322],"development":[324],"bioavailable":[328],"agents":[329],"clinic.":[334],"Citation":[335],"Format:":[336],"Pottayil":[337],"G.":[338],"Sasikumar,":[339],"Chennakrishnareddy":[340],"Gundala,":[341],"Wesley":[342],"R.":[343],"Balasubramanian,":[344],"Sudarshan":[345],"S.":[346,351,361],"Naremaddepalli,":[347],"Archana":[348],"Bhumireddy,":[349],"Sandeep":[350],"Patil,":[352],"Amit":[353],"A.":[354],"Dhudashiya,":[355],"Vijaysai":[356],"Rayavarapu,":[357],"Anirudha":[358],"Lakshminarasimhan,":[359],"Dodheri":[360],"Samiulla,":[362],"Kiran":[363],"Aithal,":[364],"Girish":[365],"Daginakatte,":[366],"Murali":[367],"Ramachandra.":[368],"Potent":[369],"antitumor":[370],"novel":[374],"pathway":[383],"[abstract].":[384],"In:":[385],"Proceedings":[386],"AACR-NCI-EORTC":[389],"International":[390],"Conference:":[391],"Molecular":[392],"Targets":[393],"Cancer":[395,406],"Therapeutics;":[396],"2017":[397],"Oct":[398],"26-30;":[399],"Philadelphia,":[400],"PA.":[401],"Philadelphia":[402],"(PA):":[403],"AACR;":[404],"Mol":[405],"Ther":[407],"2018;17(1":[408],"Suppl):Abstract":[409],"nr":[410],"B007.":[411]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2018-06-21T00:00:00"}